GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract HHSN272201500010CAGILE SCIENCES, INC.

Overview

Award facts

Net obligations
$2.74M
$2,743,862of $4.47M potential value
Outlays (paid to date)
$0
$0 paid of $2.74M obligated$0
Period of performance
Aug 5, 2019 to Oct 15, 2018
Ended
Modifications
9
Latest action Aug 5, 2019
Contract type
Definitive contract
PIID HHSN272201500010C

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

IGF::OT::IGF TARGETING THERAPEUTICS DEVELOPMENT TO RELIEVE BOTTLENECKS: OPTIMIZING LEAD THERAPEUTIC COMPOUNDS AGAINST INFECTIOUS PATHOGENS

Dates and value

Award date
Signed on Jun 30, 2015
Potential end of performance
Oct 14, 2018
Current value
$2,743,862Base and exercised options
Potential value (if all options are exercised)
$4,469,522

Obligations by fiscal year of action

  • FY2019: -$1,459 (de-obligation)
  • FY2018: $499,839
  • FY2017: $282,822
  • FY2016: $272,974
  • FY2015: $1,689,686

Total across 5 fiscal years: $2,743,862

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Aug 5, 2019. View on USAspending · Recipient on SAM.gov

Recipient

LocationRALEIGH, NC
UEIL9UJBZEVVDM1
CAGE code581A8
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyAGILE SCIENCES, INC.

Business types and certifications

Self-certified small disadvantaged businessFor-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Raleigh, Wake County, North Carolina 27606-5242
Congressional district (place of performance)
NC-02As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
22

Solicitation and notices

Solicitation ID
NIHAI2014007(as reported)

Contract details

Subcontracting plan
Plan not requiredB
Major program
Targetingtherapeutics development to relieve bottlenecks: optimizing lead therapeutic compounds aga
Cost Accounting Standards clause
Yes - CAS clause includedY
Certified cost or pricing data
Yes
Commercial procedures
Commercial item procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not a bundled requirementD
Consolidated requirement
No
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jun 30, 2015Base obligation at award: $1,689,686
Latest action
Aug 5, 2019 — CloseoutModification P00009; obligation change -$1,459; administrative: no change in scope or value
Latest substantive action
Feb 7, 2018 — Supplemental agreement (within scope)Modification 7
Latest funding action
Mar 21, 2018 — Funding onlyModification 8; obligation change +$499,839; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Other administrative action4
  • Funding only3
  • Supplemental agreement (within scope)1
  • Closeout1
10 actions recorded, Jun 30, 2015 to Aug 5, 2019; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$1,459
Latest action: change in base and all options
-$1,459

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
10

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2017/2017-0885-000
  • 075-2018/2018-0885-000
Object classes
  • 25.5: Research and development contracts